Oligonucleotide therapy: An emerging focus area for drug delivery in chronic inflammatory respiratory diseases

M Mehta, D Tewari, G Gupta, R Awasthi, H Singh… - Chemico-biological …, 2019 - Elsevier
Oligonucleotide-based therapies are advanced novel interventions used in the management
of various respiratory diseases such as asthma and Chronic Obstructive Pulmonary Disease …

Composition comprising a complexed (M) RNA and a naked MRNA for providing or enhancing an immunostimulatory response in a mammal and uses thereof

M Fotin-Mleczek, S Voss - US Patent 9,572,874, 2017 - Google Patents
US9572874B2 - Composition comprising a complexed (M)RNA and a naked mRNA for
providing or enhancing an immunostimulatory response in a mammal and uses thereof - Google …

Complexation of nucleic acids with disulfide-crosslinked cationic components for transfection and immunostimulation

P Baumhof, S Voss, T Kramps, KJ Kallen - US Patent 8,968,746, 2015 - Google Patents
US8968746B2 - Complexation of nucleic acids with disulfide-crosslinked cationic
components for transfection and immunostimulation - Google Patents US8968746B2 …

Immunostimulation by chemically modified RNA

I Hoerr, F Von Der Mulbe, S Pascolo - US Patent App. 11/025,858, 2005 - Google Patents
The present invention relates to an immunostimulating agent comprising at least one
chemically modified RNA. The invention furthermore relates to a vaccine which comprises at …

Nucleic acids comprising formula (NuGlXmGnNv) a and derivatives thereof as immunostimulating agent/adjuvant

T Kramps, S Voss, J Probst, I Hoerr - US Patent 9,226,959, 2016 - Google Patents
The present invention relates to nucleic acids of the general formula (I):(N u G l X m G n N v)
a and derivatives thereof as an immunostimulating agent/adjuvant and to compositions …

Nucleic Acid of Formula (I): GIXmGn, or (II): CIXmCn, in Particular as an Immune-Stimulating Agent/Adjuvant

I Hoerr, J Probst, T Ketterer, B Scheel - US Patent App. 12/375,178, 2009 - Google Patents
The present invention relates to a nucleic acid of the general formula (I): GXG., or (II): CXC,
which may be modified by a lipid. The nucleic acid of the invention acts as an immune …

Pharmaceutical compositions comprising a polynucleotide and optionally an antigen especially for vaccination

H Wagner, G Lipford, K Heeg - US Patent 7,001,890, 2006 - Google Patents
The present invention relates to pharmaceutical compositions comprising at least one
fragment of a polynucleotide, preferably at least one antigen, and optionally a …

Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof

E Raz, M Roman, D Dina - US Patent 6,589,940, 2003 - Google Patents
The invention relates to immunostimulatory oligonucleotide compositions. These
oligonucleotides comprise an immu nostimulatory octanucleotide Sequence. These …

Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends

S Agrawal, ER Kandimalla, D Yu, L Bhagat - US Patent 7,276,489, 2007 - Google Patents
The invention relates to the therapeutic use of oligonucleotides as immunostimulatory
agents in immunotherapy applications. More particularly, the invention provides …

Small molecule toll-like receptor (TLR) antagonists

GB Lipford, A Forsbach, C Zepp - US Patent 7,410,975, 2008 - Google Patents
The invention provides methods and compositions useful for modulating signaling through
Toll-like receptors. The meth ods involve contacting a TLR-expressing cell with a small …